Chlorhexidine anaphylaxis risk highlighted

The MHRA has received a number of reports of anaphylactic reactions following the use of products containing chlorhexidine.

A variety of medicinal products and medical devices, including some over-the-counter (OTC) products, contain chlorhexidine | SCIENCE PHOTO LIBRARY
A variety of medicinal products and medical devices, including some over-the-counter (OTC) products, contain chlorhexidine | SCIENCE PHOTO LIBRARY

Any allergic reactions to products containing chlorhexidine must be reported to the MHRA.

Chlorhexidine is present in a wide range of topical and oromucosal antiseptic products, including creams, wipes, mouthwashes, toothpastes, throat sprays and dressings.

Advice

The recommended advice for healthcare professionals is to:

  • Be aware of the potential for an anaphylactic reaction to chlorhexidine
  • Ensure all known allergies are recorded in patients' notes
  • For patients with a known allergy, check product information prior to use to establish if it contains chlorhexidine
  • If a patient experiences an unexplained reaction, check whether chlorhexidine was used or was impregnated in a medical device that was used.

MHRA Medical Device Alert

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Third tiotropium inhaler adds to treatment options for COPD patients

Third tiotropium inhaler adds to treatment options for COPD patients

Tiogiva is a new breath-actuated inhaler containing...

Drug price changes - live tracker

Drug price changes - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...

New shingles vaccine awaits decision on NHS use

New shingles vaccine awaits decision on NHS use

Shingrix, which is now available privately in the UK,...

Products coming soon - live tracker

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...